Literature DB >> 22358559

The culture of rat myeloma and rat hybridoma cells in a protein-free medium.

M J Keen1.   

Abstract

Y0 is a rat x rat hybridoma cell line, which does not secrete immunoglobulin, produced using a fusion partner derived from the Y3 (Y3,Ag.1.2.3) rat myoloma cell line. Y0 and Y3 have both been widely used as fusion partners in the production of rat x rat hybridomas. Y0 has also been used in recombinant gene technology. Y0 cells grown in shake flask culture, using RPMI 1640 medium with 4mM l-glutamine and 5% foetal bovine serum, reached a maximal cell density of 1.5×10(6) cells ml(-1) with 86% viability. Y0 cells which has been adapted to grow in ABC protein-free medium reached a maximal density, in shake flask culture, of 8.75×10(5) cells ml(-1) with 79% viability. An improved protein-free medium, designated W38 medium, was developed. In shake flask culture, W38 medium supported Y0 cell growth to a density of 2.02×10(6) cells ml(-1) with 96% viability. Two Y3 hybridomas, YID 13.9.4 cells and SAM 618 cells were adapted to growth in W38 medium. For both hybridomas, cell growth and product yield in shake flask culture using W38 medium was superior to that obtained with serum-containing RPMI 1640 medium.

Entities:  

Year:  1995        PMID: 22358559     DOI: 10.1007/BF00749657

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  16 in total

1.  CLONAL GROWTH OF MAMMALIAN CELLS IN A CHEMICALLY DEFINED, SYNTHETIC MEDIUM.

Authors:  R G HAM
Journal:  Proc Natl Acad Sci U S A       Date:  1965-02       Impact factor: 11.205

2.  Plaque production by the polyoma virus.

Authors:  R DULBECCO; G FREEMAN
Journal:  Virology       Date:  1959-07       Impact factor: 3.616

3.  Growth of the malignant and nonmalignant human squamous cells in a protein-free defined medium.

Authors:  K Rikimaru; H Toda; N Tachikawa; N Kamata; S Enomoto
Journal:  In Vitro Cell Dev Biol       Date:  1990-09

4.  Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H.

Authors:  G Hale; M J Dyer; M R Clark; J M Phillips; R Marcus; L Riechmann; G Winter; H Waldmann
Journal:  Lancet       Date:  1988-12-17       Impact factor: 79.321

5.  Various cell lines grow in protein-free hybridoma medium.

Authors:  J Kovár
Journal:  In Vitro Cell Dev Biol       Date:  1989-05

6.  A protein-free medium for the growth of hybridomas and other cells of the immune system.

Authors:  F J Darfler
Journal:  In Vitro Cell Dev Biol       Date:  1990-08

7.  A survey of commercially available tissue culture media.

Authors:  H J Morton
Journal:  In Vitro       Date:  1970 Sep-Oct

8.  Rat x rat hybrid myelomas and a monoclonal anti-Fd portion of mouse IgG.

Authors:  G Galfrè; C Milstein; B Wright
Journal:  Nature       Date:  1979-01-11       Impact factor: 49.962

9.  Three rat monoclonal antibodies to human C3.

Authors:  P J Lachmann; R G Oldroyd; C Milstein; B W Wright
Journal:  Immunology       Date:  1980-11       Impact factor: 7.397

10.  Rat monoclonal antitubulin antibodies derived by using a new nonsecreting rat cell line.

Authors:  J V Kilmartin; B Wright; C Milstein
Journal:  J Cell Biol       Date:  1982-06       Impact factor: 10.539

View more
  3 in total

1.  Adaptation of cholesterol-requiring NS0 mouse myeloma cells to high density growth in a fully defined protein-free and cholesterol-free culture medium.

Authors:  M J Keen; T W Steward
Journal:  Cytotechnology       Date:  1995-10       Impact factor: 2.058

2.  Fucose content of monoclonal antibodies can be controlled by culture medium osmolality for high antibody-dependent cellular cytotoxicity.

Authors:  Yoshinobu Konno; Yuki Kobayashi; Ken Takahashi; Eiji Takahashi; Shinji Sakae; Masako Wakitani; Kazuya Yamano; Toshiyuki Suzawa; Keiichi Yano; Toshio Ohta; Masamichi Koike; Kaori Wakamatsu; Shinji Hosoi
Journal:  Cytotechnology       Date:  2011-08-27       Impact factor: 2.058

3.  The use of serum-free medium for the production of functionally active humanised monoclonal antibody from NS0 mouse myeloma cells engineered using glutamine synthetase as a selectable marker.

Authors:  M J Keen; C Hale
Journal:  Cytotechnology       Date:  1995-01       Impact factor: 2.058

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.